Mahlapuu Margit, Håkansson Joakim, Ringstad Lovisa, Björn Camilla
Promore Pharma AB, Karolinska Institutet Science ParkSolna, Sweden; The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, The Sahlgrenska Academy at University of GothenburgGothenburg, Sweden.
SP Technical Research Institute of Sweden, Chemistry, Materials, and Surfaces Borås, Sweden.
Front Cell Infect Microbiol. 2016 Dec 27;6:194. doi: 10.3389/fcimb.2016.00194. eCollection 2016.
Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems. Against a background of rapidly increasing resistance development to conventional antibiotics all over the world, efforts to bring AMPs into clinical use are accelerating. Several AMPs are currently being evaluated in clinical trials as novel anti-infectives, but also as new pharmacological agents to modulate the immune response, promote wound healing, and prevent post-surgical adhesions. In this review, we provide an overview of the biological role, classification, and mode of action of AMPs, discuss the opportunities and challenges to develop these peptides for clinical applications, and review the innovative formulation strategies for application of AMPs.
抗菌肽(AMPs),也被称为宿主防御肽,是一类短小且通常带正电荷的肽,存在于从微生物到人类等各种各样的生命形式中。大多数抗菌肽能够直接杀死微生物病原体,而其他一些则通过调节宿主防御系统间接发挥作用。在全球范围内对传统抗生素的耐药性迅速增加的背景下,将抗菌肽投入临床使用的努力正在加速。目前有几种抗菌肽正在临床试验中作为新型抗感染药物进行评估,同时也作为调节免疫反应、促进伤口愈合和预防术后粘连的新药理学制剂进行评估。在这篇综述中,我们概述了抗菌肽的生物学作用、分类和作用模式,讨论了将这些肽开发用于临床应用的机遇和挑战,并综述了抗菌肽应用的创新制剂策略。